SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-23-000094
Filing Date
2023-10-17
Accepted
2023-10-17 07:33:25
Documents
19
Period of Report
2023-10-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20231017.htm   iXBRL 8-K 36039
2 EX-99.1 a2023q3exhibit991.htm EX-99.1 63799
3 EX-99.2 a2023q3exhibit992.htm EX-99.2 1327406
8 logo.jpg GRAPHIC 17029
9 overallresultsupdated.jpg GRAPHIC 27690
10 regionupdated.jpg GRAPHIC 16907
11 segmentsupdated.jpg GRAPHIC 18020
  Complete submission text file 0000200406-23-000094.txt   1789246

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20231017.xsd EX-101.SCH 3333
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20231017_def.xml EX-101.DEF 16713
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20231017_lab.xml EX-101.LAB 34199
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20231017_pre.xml EX-101.PRE 17560
13 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20231017_htm.xml XML 6218
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 231328453
SIC: 2834 Pharmaceutical Preparations